D-0140-2024 Class III Terminated
FDA drug recall D-0140-2024 was initiated by Right Value Drug Stores, LLC Dba Carie Boyd's Prescription Shop on Nov 9, 2023 and is designated Class III. Reason for recall: Product Mix-up: Incorrect Product Formulation The recall status is terminated (terminated Aug 20, 2024). Affected quantity: 190 syringes.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 13, 2023
- Initiation Date
- Nov 9, 2023
- Termination Date
- Aug 20, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 190 syringes
Product description
LET Gel (Lidocaine HCL/Epinephrine Bitartrate/Tetracaine HCL 4%/0.18%/0.5% Topical Gel), Single-use Topical Syringe, 3mL syringe, 10/pack, Rx only, Carie Boyd Pharmaceuticals, 8400 Esters Blvd, Ste# 190, Irving, TX 75063, NDC73271-1003-1
Reason for recall
Product Mix-up: Incorrect Product Formulation
Distribution pattern
USA Nationwide
Code information
Lot#: 09202023@7, Exp 03/18/2024
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0140-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026